POTASSIUM CHLORIDE

POTASSIUM CHLORIDE was reported 115163 times

These side effects are most commonly reported by patients taking POTASSIUM CHLORIDE:

# Side effect Count
0 DIARRHOEA 8391
1 DYSPNOEA 8319
2 NAUSEA 8045
3 FATIGUE 8037
4 DEATH 5781
5 PNEUMONIA 5515
6 HEADACHE 5234
7 ASTHENIA 5151
8 DIZZINESS 5044
9 VOMITING 4967
10 PAIN 4928
11 OFF LABEL USE 4772
12 FALL 4686
13 DRUG INEFFECTIVE 4538
14 ANAEMIA 3739
15 WEIGHT DECREASED 3687
16 MALAISE 3654
17 HYPOTENSION 3650
18 PYREXIA 3558
19 COUGH 3481
20 ACUTE KIDNEY INJURY 3403
21 CONSTIPATION 3128
22 ARTHRALGIA 3091
23 OEDEMA PERIPHERAL 3049
24 PAIN IN EXTREMITY 2947
25 DECREASED APPETITE 2885
26 ABDOMINAL PAIN 2830
27 RENAL FAILURE 2773
28 RASH 2717
29 BACK PAIN 2699
30 CARDIAC FAILURE CONGESTIVE 2687
31 DEHYDRATION 2636
32 ATRIAL FIBRILLATION 2621
33 URINARY TRACT INFECTION 2619
34 CHEST PAIN 2518
35 ANXIETY 2439
36 PRURITUS 2390
37 CONDITION AGGRAVATED 2384
38 HYPERTENSION 2348
39 SEPSIS 2278
40 HYPOKALAEMIA 2244
41 WEIGHT INCREASED 2135
42 CHRONIC KIDNEY DISEASE 2134
43 PERIPHERAL SWELLING 2125
44 INSOMNIA 2080
45 DEPRESSION 2060
46 GASTROINTESTINAL HAEMORRHAGE 2055
47 SOMNOLENCE 1956
48 FEELING ABNORMAL 1903
49 ABDOMINAL PAIN UPPER 1862
50 PRODUCT DOSE OMISSION ISSUE 1808
51 MUSCLE SPASMS 1806
52 GAIT DISTURBANCE 1757
53 CONFUSIONAL STATE 1752
54 HAEMOGLOBIN DECREASED 1645
55 MYOCARDIAL INFARCTION 1625
56 PLATELET COUNT DECREASED 1588
57 DRUG INTERACTION 1585
58 FLUID RETENTION 1555
59 BLOOD GLUCOSE INCREASED 1504
60 BLOOD PRESSURE INCREASED 1494
61 THROMBOCYTOPENIA 1489
62 BRONCHITIS 1480
63 GASTROOESOPHAGEAL REFLUX DISEASE 1465
64 RESPIRATORY FAILURE 1465
65 ABDOMINAL DISTENSION 1456
66 CEREBROVASCULAR ACCIDENT 1449
67 PLEURAL EFFUSION 1446
68 ABDOMINAL DISCOMFORT 1442
69 CARDIAC FAILURE 1431
70 TREMOR 1430
71 BLOOD POTASSIUM DECREASED 1399
72 SYNCOPE 1397
73 NASOPHARYNGITIS 1395
74 ERYTHEMA 1369
75 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1363
76 DRUG HYPERSENSITIVITY 1341
77 WHITE BLOOD CELL COUNT DECREASED 1341
78 NEUTROPENIA 1340
79 ALOPECIA 1300
80 FEBRILE NEUTROPENIA 1296
81 COVID-19 1289
82 INFECTION 1289
83 NEUROPATHY PERIPHERAL 1288
84 EPISTAXIS 1285
85 MYALGIA 1285
86 CONTUSION 1278
87 MUSCULAR WEAKNESS 1253
88 HYPOAESTHESIA 1252
89 GENERAL PHYSICAL HEALTH DETERIORATION 1247
90 PALPITATIONS 1226
91 HYPERKALAEMIA 1223
92 SINUSITIS 1215
93 PULMONARY EMBOLISM 1210
94 CARDIAC ARREST 1189
95 HYPONATRAEMIA 1189
96 CHEST DISCOMFORT 1177
97 OEDEMA 1175
98 DISEASE PROGRESSION 1172
99 LOSS OF CONSCIOUSNESS 1165
100 OXYGEN SATURATION DECREASED 1144
101 CHILLS 1141
102 DYSPNOEA EXERTIONAL 1140
103 DYSPEPSIA 1121
104 HYPERHIDROSIS 1117
105 PRODUCT USE IN UNAPPROVED INDICATION 1111
106 HEART RATE INCREASED 1096
107 PARAESTHESIA 1088
108 RENAL FAILURE ACUTE 1085
109 CELLULITIS 1073
110 BLOOD CREATININE INCREASED 1071
111 INFLUENZA 1067
112 SWELLING 1050
113 MEMORY IMPAIRMENT 1047
114 TACHYCARDIA 1039
115 FLUSHING 1035
116 VISION BLURRED 1033
117 CARDIAC DISORDER 1031
118 THROMBOSIS 1031
119 HOSPITALISATION 1000
120 PRODUCT USE ISSUE 999
121 JOINT SWELLING 987
122 DYSPHAGIA 970
123 HYPOXIA 963
124 DEEP VEIN THROMBOSIS 951
125 BALANCE DISORDER 949
126 PANCYTOPENIA 938
127 BLOOD PRESSURE DECREASED 930
128 ASTHMA 920
129 HYPERSENSITIVITY 910
130 PULMONARY OEDEMA 904
131 DIABETES MELLITUS 895
132 PULMONARY HYPERTENSION 894
133 ILLNESS 893
134 HAEMORRHAGE 890
135 DRY MOUTH 885
136 RECTAL HAEMORRHAGE 884
137 INJECTION SITE PAIN 869
138 RENAL IMPAIRMENT 869
139 DRUG INTOLERANCE 843
140 PRODUCTIVE COUGH 826
141 INCORRECT DOSE ADMINISTERED 825
142 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 814
143 OROPHARYNGEAL PAIN 807
144 ARTHRITIS 804
145 ASCITES 801
146 SEPTIC SHOCK 801
147 UNEVALUABLE EVENT 799
148 BRADYCARDIA 793
149 STRESS 789
150 HALLUCINATION 783
151 INJURY 772
152 URTICARIA 770
153 INTERNATIONAL NORMALISED RATIO INCREASED 759
154 DRUG DOSE OMISSION 754
155 VISUAL IMPAIRMENT 753
156 GASTROINTESTINAL DISORDER 743
157 MIGRAINE 740
158 UPPER RESPIRATORY TRACT INFECTION 733
159 ASPARTATE AMINOTRANSFERASE INCREASED 728
160 ACUTE RESPIRATORY FAILURE 723
161 NASAL CONGESTION 723
162 TOXICITY TO VARIOUS AGENTS 718
163 ALANINE AMINOTRANSFERASE INCREASED 713
164 HAEMATOCHEZIA 702
165 STOMATITIS 699
166 END STAGE RENAL DISEASE 692
167 EMOTIONAL DISTRESS 688
168 MALIGNANT NEOPLASM PROGRESSION 684
169 OVERDOSE 682
170 WHEEZING 675
171 DRY SKIN 669
172 SEIZURE 651
173 CATARACT 649
174 COLITIS 643
175 MENTAL STATUS CHANGES 636
176 NECK PAIN 626
177 INFUSION RELATED REACTION 621
178 LETHARGY 620
179 CORONARY ARTERY DISEASE 619
180 ARRHYTHMIA 617
181 COMA 615
182 CYSTITIS 613
183 INFUSION SITE PAIN 613
184 SLEEP DISORDER 608
185 MUSCULOSKELETAL PAIN 607
186 DYSPHONIA 601
187 HYPOGLYCAEMIA 601
188 PNEUMONIA ASPIRATION 600
189 PAIN IN JAW 597
190 MOBILITY DECREASED 594
191 RHINORRHOEA 588
192 HOT FLUSH 587
193 OSTEOARTHRITIS 577
194 AGITATION 573
195 FLATULENCE 568
196 LUNG DISORDER 564
197 RENAL INJURY 564
198 DIVERTICULITIS 560
199 AMNESIA 556
200 RHEUMATOID ARTHRITIS 552
201 MUSCULOSKELETAL STIFFNESS 540
202 COMPLETED SUICIDE 539
203 TRANSIENT ISCHAEMIC ATTACK 537
204 PLASMA CELL MYELOMA 532
205 HERPES ZOSTER 528
206 INTENTIONAL PRODUCT MISUSE 525
207 BONE PAIN 522
208 DYSGEUSIA 519
209 SEASONAL ALLERGY 518
210 HEPATIC ENZYME INCREASED 516
211 ECONOMIC PROBLEM 509
212 FLUID OVERLOAD 508
213 OSTEOPOROSIS 505
214 RENAL DISORDER 505
215 SLEEP APNOEA SYNDROME 505
216 GOUT 503
217 HAEMOPTYSIS 503
218 CARDIOGENIC SHOCK 502
219 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 502
220 CARDIO-RESPIRATORY ARREST 501
221 HYPERGLYCAEMIA 501
222 PERICARDIAL EFFUSION 501
223 C-REACTIVE PROTEIN INCREASED 499
224 BLOOD CHOLESTEROL INCREASED 498
225 MULTIPLE ORGAN DYSFUNCTION SYNDROME 496
226 NEUTROPHIL COUNT DECREASED 496
227 CHOLELITHIASIS 495
228 CARDIOMEGALY 494
229 CYTOKINE RELEASE SYNDROME 492
230 BLISTER 489
231 BLOOD UREA INCREASED 489
232 WHITE BLOOD CELL COUNT INCREASED 488
233 NEPHROLITHIASIS 485
234 HEAD INJURY 484
235 TREATMENT NONCOMPLIANCE 478
236 SWELLING FACE 476
237 BLOOD BILIRUBIN INCREASED 475
238 STAPHYLOCOCCAL INFECTION 471
239 HAEMATOCRIT DECREASED 468
240 MITRAL VALVE INCOMPETENCE 468
241 THROAT IRRITATION 467
242 HAEMATURIA 466
243 PULMONARY ARTERIAL HYPERTENSION 466
244 RESPIRATORY DISTRESS 466
245 DYSURIA 464
246 HYPERLIPIDAEMIA 460
247 INTENTIONAL PRODUCT USE ISSUE 459
248 RED BLOOD CELL COUNT DECREASED 456
249 EYE PAIN 453
250 HYPOMAGNESAEMIA 451
251 MACULAR DEGENERATION 451
252 BLOOD ALKALINE PHOSPHATASE INCREASED 450
253 BURNING SENSATION 450
254 THERAPY INTERRUPTED 449
255 THERAPY NON-RESPONDER 449
256 FEELING HOT 446
257 ELECTROCARDIOGRAM QT PROLONGED 440
258 UPPER GASTROINTESTINAL HAEMORRHAGE 439
259 SKIN EXFOLIATION 438
260 ACUTE MYOCARDIAL INFARCTION 437
261 PRODUCT DOSE OMISSION 436
262 ARTHROPATHY 433
263 POLLAKIURIA 426
264 VENTRICULAR TACHYCARDIA 426
265 ATELECTASIS 424
266 INFLUENZA LIKE ILLNESS 424
267 ANHEDONIA 423
268 BLOOD GLUCOSE DECREASED 423
269 PRODUCT QUALITY ISSUE 422
270 VENTRICULAR FIBRILLATION 422
271 VERTIGO 422
272 ADVERSE DRUG REACTION 420
273 LEUKOPENIA 415
274 HAEMATOMA 411
275 SKIN DISCOLOURATION 410
276 HYPOTHYROIDISM 409
277 RASH PRURITIC 409
278 PANCREATITIS 407
279 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 405
280 TINNITUS 403
281 CONVULSION 401
282 LABORATORY TEST ABNORMAL 401
283 HEART RATE DECREASED 399
284 COAGULOPATHY 398
285 DEMENTIA 397
286 HEART RATE IRREGULAR 395
287 ENCEPHALOPATHY 394
288 INTERSTITIAL LUNG DISEASE 393
289 NERVOUSNESS 393
290 NEPHROGENIC ANAEMIA 392
291 ADVERSE EVENT 381
292 INFUSION SITE ERYTHEMA 381
293 BACTERIAL INFECTION 379
294 URINARY RETENTION 379
295 BLOOD POTASSIUM INCREASED 378
296 SPEECH DISORDER 378
297 INJECTION SITE ERYTHEMA 375
298 CARDIOMYOPATHY 374
299 HIP FRACTURE 374
300 LEUKOCYTOSIS 373
301 INTESTINAL OBSTRUCTION 372
302 SURGERY 372
303 FULL BLOOD COUNT DECREASED 371
304 MEDICATION ERROR 368
305 DYSARTHRIA 366
306 ORAL CANDIDIASIS 364
307 PROCEDURAL PAIN 364
308 PRESYNCOPE 363
309 UNRESPONSIVE TO STIMULI 363
310 NEURALGIA 359
311 TOXIC EPIDERMAL NECROLYSIS 358
312 ELECTROLYTE IMBALANCE 357
313 TYPE 2 DIABETES MELLITUS 357
314 URINARY INCONTINENCE 357
315 ILL-DEFINED DISORDER 355
316 GASTRITIS 354
317 HAEMORRHOIDS 354
318 FREQUENT BOWEL MOVEMENTS 353
319 LIVER DISORDER 353
320 ORTHOSTATIC HYPOTENSION 353
321 BLOOD SODIUM DECREASED 350
322 FIBROMYALGIA 349
323 DISORIENTATION 348
324 GLAUCOMA 348
325 HYPOPHAGIA 348
326 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 348
327 HYPOCALCAEMIA 347
328 MELAENA 344
329 RIGHT VENTRICULAR FAILURE 341
330 FUNGAL INFECTION 340
331 RHABDOMYOLYSIS 340
332 PSORIASIS 339
333 CEREBRAL HAEMORRHAGE 334
334 SKIN ULCER 334
335 METABOLIC ACIDOSIS 333
336 VIRAL INFECTION 333
337 LIMB INJURY 331
338 CLOSTRIDIUM DIFFICILE INFECTION 330
339 DEVICE ISSUE 330
340 CLOSTRIDIUM DIFFICILE COLITIS 328
341 DELIRIUM 326
342 LOCALISED INFECTION 324
343 DISCOMFORT 323
344 HIATUS HERNIA 323
345 COGNITIVE DISORDER 322
346 HYPOACUSIS 322
347 HYPERSOMNIA 321
348 TRICUSPID VALVE INCOMPETENCE 319
349 BLOOD MAGNESIUM DECREASED 317
350 LYMPHOEDEMA 317
351 RIB FRACTURE 316
352 PNEUMONITIS 313
353 HEPATIC FAILURE 312
354 NEOPLASM MALIGNANT 311
355 ATRIAL FLUTTER 310
356 LACTIC ACIDOSIS 310
357 DRY EYE 309
358 RESPIRATORY TRACT INFECTION 309
359 UNDERDOSE 307
360 TREATMENT FAILURE 306
361 DERMATITIS CONTACT 305
362 EJECTION FRACTION DECREASED 305
363 ROAD TRAFFIC ACCIDENT 304
364 MULTI-ORGAN FAILURE 302
365 GENERALISED OEDEMA 301
366 RASH ERYTHEMATOUS 301
367 HYPERVOLAEMIA 297
368 HYPOPHOSPHATAEMIA 297
369 COLITIS ULCERATIVE 295
370 EYE IRRITATION 295
371 LIVER FUNCTION TEST ABNORMAL 295
372 PARAESTHESIA ORAL 294
373 SINUS DISORDER 294
374 ANGINA PECTORIS 292
375 DEVICE MALFUNCTION 290
376 OBESITY 289
377 DEPRESSED LEVEL OF CONSCIOUSNESS 287
378 APHASIA 283
379 RESPIRATORY DISORDER 283
380 INFUSION SITE SWELLING 282
381 LYMPHOCYTE COUNT DECREASED 282
382 NIGHT SWEATS 280
383 NO ADVERSE EVENT 280
384 ULCER 280
385 ANAPHYLACTIC REACTION 279
386 APPENDICITIS 279
387 CHRONIC SINUSITIS 279
388 JOINT INJURY 278
389 DISTURBANCE IN ATTENTION 277
390 MALNUTRITION 277
391 INTERVERTEBRAL DISC PROTRUSION 275
392 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 273
393 INFLAMMATION 273
394 VENTRICULAR EXTRASYSTOLES 273
395 HEPATIC CIRRHOSIS 272
396 ORAL PAIN 271
397 FEAR 270
398 LOWER RESPIRATORY TRACT INFECTION 269
399 LYMPHADENOPATHY 269
400 LOWER GASTROINTESTINAL HAEMORRHAGE 268
401 DEVICE RELATED INFECTION 267
402 DYSSTASIA 267
403 GASTRIC DISORDER 267
404 CARDIAC MURMUR 266
405 TUBULOINTERSTITIAL NEPHRITIS 266
406 IRON DEFICIENCY ANAEMIA 265
407 OCULAR HYPERAEMIA 265
408 ABASIA 264
409 THERAPY CESSATION 263
410 PULMONARY MASS 262
411 FEELING COLD 261
412 LUNG INFILTRATION 261
413 TASTE DISORDER 260
414 LIMB DISCOMFORT 259
415 HAEMATEMESIS 258
416 INJECTION SITE HAEMORRHAGE 258
417 MULTIPLE SCLEROSIS RELAPSE 258
418 SMALL INTESTINAL OBSTRUCTION 258
419 FEMUR FRACTURE 257
420 MUCOSAL INFLAMMATION 256
421 RETCHING 255
422 SUICIDAL IDEATION 255
423 DEPRESSED MOOD 254
424 FAECES DISCOLOURED 254
425 IMPAIRED HEALING 254
426 RADICULOPATHY 254
427 SKIN LESION 252
428 EAR INFECTION 251
429 RESPIRATORY ARREST 251
430 BACTERAEMIA 250
431 MULTIPLE INJURIES 250
432 RESTLESSNESS 249
433 THERAPEUTIC RESPONSE DECREASED 248
434 HAEMORRHAGIC ANAEMIA 247
435 INJECTION SITE BRUISING 247
436 BLOOD PRESSURE ABNORMAL 246
437 BREAST CANCER 246
438 LACRIMATION INCREASED 246
439 TACHYPNOEA 246
440 MATERNAL EXPOSURE DURING PREGNANCY 244
441 SINUS TACHYCARDIA 243
442 KIDNEY INFECTION 242
443 EYE SWELLING 241
444 RALES 241
445 THERAPEUTIC RESPONSE UNEXPECTED 240
446 GASTRIC ULCER 239
447 IRRITABILITY 239
448 RASH MACULAR 239
449 GAIT INABILITY 238
450 PULMONARY CONGESTION 238
451 RESPIRATORY TRACT CONGESTION 238
452 RESTLESS LEGS SYNDROME 237
453 BLINDNESS 236
454 RENAL FAILURE CHRONIC 236
455 HEPATIC STEATOSIS 235
456 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 235
457 PANCREATITIS ACUTE 235
458 HYPOVOLAEMIA 234
459 SYNOVITIS 234
460 SUBDURAL HAEMATOMA 233
461 DIABETES MELLITUS INADEQUATE CONTROL 231
462 SHOCK 231
463 AGEUSIA 230
464 CANDIDA INFECTION 230
465 DYSKINESIA 229
466 EMPHYSEMA 229
467 HERNIA 228
468 JAUNDICE 227
469 BLOOD ALBUMIN DECREASED 226
470 TRANSFUSION 226
471 BLOOD URINE PRESENT 225
472 BODY HEIGHT DECREASED 225
473 INJECTION SITE PRURITUS 225
474 WOUND 225
475 HOSPICE CARE 224
476 MENTAL DISORDER 224
477 DEVICE DISLOCATION 223
478 MYASTHENIA GRAVIS 222
479 POST PROCEDURAL COMPLICATION 222
480 BLOOD PRESSURE SYSTOLIC INCREASED 221
481 GASTROENTERITIS VIRAL 221
482 ARTERIOSCLEROSIS 220
483 EYE DISORDER 220
484 HYPERPARATHYROIDISM SECONDARY 219
485 RENAL TUBULAR NECROSIS 219
486 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 218
487 BLOOD PRESSURE FLUCTUATION 218
488 GASTROENTERITIS 218
489 HEPATIC CYTOLYSIS 218
490 HEPATIC FUNCTION ABNORMAL 218
491 SCIATICA 218
492 INTENTIONAL OVERDOSE 217
493 TROPONIN INCREASED 217
494 ACCIDENTAL OVERDOSE 216
495 DIPLOPIA 216
496 MULTIPLE ALLERGIES 216
497 COLITIS MICROSCOPIC 215
498 GAMMA-GLUTAMYLTRANSFERASE INCREASED 215
499 DIVERTICULUM 214
500 LUNG INFECTION 214
501 SPINAL FRACTURE 214
502 FOOT FRACTURE 213
503 LIVER FUNCTION TEST INCREASED 213
504 PALLOR 213
505 ARTERIOSCLEROSIS CORONARY ARTERY 212
506 BREATH SOUNDS ABNORMAL 212
507 OESOPHAGITIS 212
508 RASH MACULO-PAPULAR 212
509 SINUS CONGESTION 212
510 APPENDICOLITH 211
511 MUSCULOSKELETAL CHEST PAIN 211
512 OSTEOMYELITIS 211
513 BLOOD TEST ABNORMAL 210
514 SKIN DISORDER 210
515 SPINAL OSTEOARTHRITIS 210
516 THYROID DISORDER 210
517 UPPER LIMB FRACTURE 210
518 FEEDING DISORDER 209
519 ACUTE RESPIRATORY DISTRESS SYNDROME 208
520 CONTRAINDICATED PRODUCT ADMINISTERED 208
521 ECZEMA 208
522 VASCULAR DEVICE INFECTION 208
523 SWOLLEN TONGUE 207
524 DRUG EFFECT DECREASED 206
525 FEMALE GENITAL TRACT FISTULA 206
526 HYPERCALCAEMIA 206
527 ILEUS 206
528 MOUTH ULCERATION 206
529 ADRENAL INSUFFICIENCY 205
530 DRUG DEPENDENCE 205
531 ELECTROCARDIOGRAM ABNORMAL 205
532 PROTHROMBIN TIME PROLONGED 205
533 VISUAL ACUITY REDUCED 205
534 PHARMACEUTICAL PRODUCT COMPLAINT 204
535 GALLBLADDER DISORDER 203
536 SUPRAVENTRICULAR TACHYCARDIA 203
537 TOOTH DISORDER 203
538 CORONARY ARTERY OCCLUSION 202
539 INTENTIONAL DOSE OMISSION 202
540 NEOPLASM PROGRESSION 202
541 PROCTITIS 202
542 BLOOD IRON DECREASED 200
543 LUNG NEOPLASM MALIGNANT 200
544 DEVICE LEAKAGE 199
545 OSTEOPENIA 199
546 VAGINAL DISCHARGE 199
547 INTERNAL HAEMORRHAGE 198
548 ORTHOPNOEA 198
549 BLOOD CALCIUM DECREASED 197
550 INFUSION SITE HAEMORRHAGE 197
551 PANIC ATTACK 197
552 STEVENS-JOHNSON SYNDROME 197
553 ACTIVITIES OF DAILY LIVING IMPAIRED 196
554 BONE DISORDER 196
555 TRANSAMINASES INCREASED 196
556 AORTIC STENOSIS 195
557 CIRCULATORY COLLAPSE 195
558 VAGINAL HAEMORRHAGE 195
559 CROHN^S DISEASE 194
560 INTERVERTEBRAL DISC DEGENERATION 194
561 BLOOD URIC ACID INCREASED 193
562 EATING DISORDER 192
563 PRODUCT DOSE OMISSION IN ERROR 192
564 SKIN LACERATION 192
565 BACK DISORDER 190
566 DEVICE OCCLUSION 190
567 BODY TEMPERATURE INCREASED 189
568 DISEASE RECURRENCE 189
569 LIP SWELLING 189
570 FOETAL EXPOSURE DURING PREGNANCY 188
571 BLOOD CREATINE PHOSPHOKINASE INCREASED 187
572 MUSCULOSKELETAL DISCOMFORT 187
573 BONE MARROW FAILURE 186
574 COVID-19 PNEUMONIA 186
575 LEFT VENTRICULAR DYSFUNCTION 186
576 UROSEPSIS 186
577 DIZZINESS POSTURAL 185
578 HYPOALBUMINAEMIA 185
579 IMPAIRED GASTRIC EMPTYING 185
580 PULMONARY FIBROSIS 185
581 EAR PAIN 184
582 VAGINAL FLATULENCE 184
583 AGRANULOCYTOSIS 183
584 ANKLE FRACTURE 183
585 OSTEONECROSIS OF JAW 183
586 PNEUMOTHORAX 183
587 ANGIOEDEMA 182
588 HYPERCHOLESTEROLAEMIA 182
589 WRONG TECHNIQUE IN DRUG USAGE PROCESS 182
590 BLOOD TRIGLYCERIDES INCREASED 181
591 CHOLESTASIS 181
592 DECUBITUS ULCER 181
593 MULTIPLE SCLEROSIS 181
594 HAEMOGLOBIN INCREASED 180
595 ACUTE MYELOID LEUKAEMIA 179
596 BLOOD PHOSPHORUS INCREASED 179
597 CARDIOVASCULAR DISORDER 179
598 CYANOSIS 179
599 VITAMIN D DEFICIENCY 179
600 SINUS BRADYCARDIA 178
601 THERAPEUTIC AGENT TOXICITY 178
602 HYPERPHOSPHATAEMIA 177
603 ABSCESS 176
604 AGGRESSION 176
605 DRUG WITHDRAWAL SYNDROME 176
606 EMOTIONAL DISORDER 176
607 HAEMORRHAGE INTRACRANIAL 176
608 LOWER LIMB FRACTURE 176
609 NERVOUS SYSTEM DISORDER 176
610 CARDIAC FAILURE ACUTE 175
611 HEMIPARESIS 175
612 FAILURE TO THRIVE 174
613 RENAL CYST 172
614 BLOOD COUNT ABNORMAL 171
615 CEREBRAL INFARCTION 171
616 NOCTURIA 171
617 EYE PRURITUS 170
618 CHOKING 169
619 CHOLECYSTITIS 169
620 GLOMERULAR FILTRATION RATE DECREASED 169
621 IRRITABLE BOWEL SYNDROME 169
622 KNEE ARTHROPLASTY 169
623 SYSTEMIC LUPUS ERYTHEMATOSUS 169
624 WRIST FRACTURE 169
625 ASPIRATION 168
626 DEAFNESS 168
627 SNEEZING 168
628 TOOTHACHE 168
629 ATRIOVENTRICULAR BLOCK FIRST DEGREE 167
630 MYOCARDIAL ISCHAEMIA 167
631 PREMATURE BABY 167
632 ROTATOR CUFF SYNDROME 167
633 PRODUCT USE COMPLAINT 166
634 THERAPEUTIC PRODUCT EFFECT DECREASED 165
635 URINE OUTPUT DECREASED 165
636 PERITONITIS 164
637 SUICIDE ATTEMPT 164
638 HAIR COLOUR CHANGES 163
639 HAIR TEXTURE ABNORMAL 163
640 IRON DEFICIENCY 163
641 REBOUND ACID HYPERSECRETION 163
642 WEIGHT FLUCTUATION 163
643 BLOOD CALCIUM INCREASED 162
644 HALLUCINATION, VISUAL 162
645 COLD SWEAT 161
646 INCREASED TENDENCY TO BRUISE 160
647 INJECTION SITE SWELLING 160
648 LOCAL SWELLING 160
649 NIGHTMARE 160
650 SPLENOMEGALY 160
651 CARPAL TUNNEL SYNDROME 158
652 CRYING 157
653 ERUCTATION 157
654 ISCHAEMIC CARDIOMYOPATHY 157
655 MOVEMENT DISORDER 157
656 POOR QUALITY SLEEP 157
657 PSORIATIC ARTHROPATHY 157
658 SPUTUM DISCOLOURED 157
659 BENIGN PROSTATIC HYPERPLASIA 156
660 DRUG-INDUCED LIVER INJURY 156
661 FULL BLOOD COUNT ABNORMAL 156
662 GLYCOSYLATED HAEMOGLOBIN INCREASED 156
663 IMMUNODEFICIENCY 156
664 ISCHAEMIC STROKE 156
665 OSTEONECROSIS 156
666 PRODUCT ADMINISTRATION ERROR 156
667 INFUSION SITE INFECTION 155
668 MYELOSUPPRESSION 155
669 THROAT TIGHTNESS 155
670 DISSEMINATED INTRAVASCULAR COAGULATION 153
671 JOINT STIFFNESS 153
672 PERIPHERAL VASCULAR DISORDER 153
673 PRURITUS GENERALISED 153
674 SHOCK HAEMORRHAGIC 153
675 ABNORMAL BEHAVIOUR 152
676 BLOOD LACTATE DEHYDROGENASE INCREASED 152
677 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 152
678 ANOREXIA 151
679 HYPERTHYROIDISM 151
680 INSURANCE ISSUE 151
681 LEFT VENTRICULAR HYPERTROPHY 151
682 INFUSION SITE DISCHARGE 150
683 MICTURITION URGENCY 150
684 MUSCLE TWITCHING 150
685 AORTIC VALVE INCOMPETENCE 149
686 IMPAIRED QUALITY OF LIFE 149
687 PNEUMONIA BACTERIAL 149
688 TENDERNESS 149
689 ABDOMINAL PAIN LOWER 148
690 BRAIN NATRIURETIC PEPTIDE INCREASED 148
691 BURSITIS 148
692 CHROMATURIA 148
693 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 148
694 PULMONARY THROMBOSIS 148
695 SKIN REACTION 148
696 GINGIVAL BLEEDING 147
697 INJECTION SITE REACTION 147
698 RASH GENERALISED 147
699 MASS 146
700 CARDIAC VALVE DISEASE 145
701 HYPERBILIRUBINAEMIA 145
702 NEPHROPATHY 145
703 DEVICE INFUSION ISSUE 144
704 HEPATIC ENCEPHALOPATHY 144
705 EXERCISE TOLERANCE DECREASED 143
706 PSYCHOLOGICAL TRAUMA 143
707 METASTASES TO LIVER 142
708 PARKINSON^S DISEASE 142
709 THIRST 142
710 INCONTINENCE 141
711 NEUTROPHIL COUNT INCREASED 141
712 BRAIN FOG 140
713 BUNDLE BRANCH BLOCK LEFT 140
714 CONJUNCTIVITIS 140
715 DEVICE FAILURE 140
716 HYDRONEPHROSIS 140
717 PETECHIAE 140
718 ECCHYMOSIS 139
719 HYPERNATRAEMIA 139
720 MYELODYSPLASTIC SYNDROME 139
721 OESOPHAGEAL PAIN 139
722 PROTEINURIA 139
723 SPINAL COMPRESSION FRACTURE 139
724 WOUND INFECTION 139
725 DRUG ADMINISTRATION ERROR 137
726 POST PROCEDURAL HAEMORRHAGE 137
727 ALTERED STATE OF CONSCIOUSNESS 136
728 BEDRIDDEN 136
729 HEPATITIS 136
730 PHOTOPHOBIA 136
731 PRODUCT SUBSTITUTION ISSUE 136
732 DENTAL CARIES 135
733 INCREASED APPETITE 135
734 LACERATION 135
735 LIGAMENT SPRAIN 135
736 ABNORMAL DREAMS 134
737 FEELING JITTERY 134
738 TOOTH INFECTION 134
739 TUMOUR LYSIS SYNDROME 134
740 ESSENTIAL HYPERTENSION 133
741 HYPOKINESIA 133
742 PROSTATE CANCER 133
743 SCAR 133
744 UPPER-AIRWAY COUGH SYNDROME 133
745 EOSINOPHILIA 132
746 EXPOSURE DURING PREGNANCY 132
747 FLANK PAIN 132
748 HEPATOMEGALY 132
749 ATAXIA 131
750 COMPLICATION ASSOCIATED WITH DEVICE 131
751 ACCIDENTAL EXPOSURE TO PRODUCT 130
752 BLOOD CHLORIDE DECREASED 130
753 PRESCRIBED UNDERDOSE 130
754 SUBARACHNOID HAEMORRHAGE 130
755 COLON CANCER 129
756 MENTAL IMPAIRMENT 129
757 PRODUCT PRESCRIBING ERROR 129
758 PROSTATIC SPECIFIC ANTIGEN INCREASED 129
759 SKIN CANCER 129
760 DIABETIC KETOACIDOSIS 128
761 HAEMORRHAGIC STROKE 128
762 HAIR DISORDER 128
763 NERVE COMPRESSION 128
764 PSYCHOTIC DISORDER 128
765 SUPRAVENTRICULAR EXTRASYSTOLES 128
766 ACNE 127
767 BONE DENSITY DECREASED 127
768 DECREASED ACTIVITY 127
769 ESCHERICHIA INFECTION 127
770 POLYURIA 127
771 SECRETION DISCHARGE 127
772 CYTOPENIA 126
773 DIALYSIS 126
774 LIVER INJURY 126
775 BASAL CELL CARCINOMA 125
776 METASTASES TO BONE 125
777 OXYGEN CONSUMPTION INCREASED 125
778 PRODUCT ADMINISTRATION INTERRUPTED 125
779 LEFT VENTRICULAR FAILURE 124
780 MUSCLE ATROPHY 124
781 PSEUDOMONAS INFECTION 124
782 TORSADE DE POINTES 124
783 CARDIAC PACEMAKER INSERTION 123
784 INTERNATIONAL NORMALISED RATIO DECREASED 123
785 OESOPHAGEAL SPASM 123
786 CARDIAC FAILURE CHRONIC 122
787 CATHETERISATION CARDIAC 122
788 DRUG LEVEL INCREASED 122
789 HEAD DISCOMFORT 122
790 METABOLIC ENCEPHALOPATHY 122
791 MUSCLE TIGHTNESS 122
792 MIDDLE INSOMNIA 121
793 PRODUCT RESIDUE PRESENT 121
794 SEDATION 121
795 SKIN BURNING SENSATION 121
796 DIABETIC NEUROPATHY 120
797 GLOSSODYNIA 119
798 HAEMORRHOIDAL HAEMORRHAGE 119
799 MULTIPLE FRACTURES 119
800 PARKINSONISM 119
801 PULSE ABSENT 119
802 THINKING ABNORMAL 119
803 BLADDER DISORDER 118
804 EXTRASYSTOLES 118
805 HEPARIN-INDUCED THROMBOCYTOPENIA 118
806 INFUSION SITE REACTION 118
807 RASH PAPULAR 118
808 SKIN FISSURES 118
809 TOOTH ABSCESS 118
810 BLOOD GLUCOSE ABNORMAL 117
811 DEVICE USE ERROR 117
812 DRUG TOXICITY 117
813 EXTRA DOSE ADMINISTERED 117
814 MADAROSIS 117
815 SCOLIOSIS 117
816 SKIN HAEMORRHAGE 117
817 BRONCHOSPASM 116
818 DIASTOLIC DYSFUNCTION 116
819 HAEMODIALYSIS 116
820 WITHDRAWAL SYNDROME 116
821 DRUG ABUSE 115
822 MOTOR DYSFUNCTION 115
823 DYSLIPIDAEMIA 114
824 HEREDITARY ANGIOEDEMA 114
825 NERVE INJURY 114
826 PYELONEPHRITIS 114
827 RESPIRATORY SYNCYTIAL VIRUS INFECTION 114
828 BRAIN OEDEMA 113
829 CONGESTIVE CARDIOMYOPATHY 113
830 INITIAL INSOMNIA 113
831 NEUROTOXICITY 113
832 ATRIOVENTRICULAR BLOCK 112
833 COMPRESSION FRACTURE 112
834 EXOSTOSIS 112
835 GROIN PAIN 112
836 PELVIC FRACTURE 112
837 DIVERTICULUM INTESTINAL 111
838 EYE INFECTION 111
839 IMMUNE SYSTEM DISORDER 111
840 TOOTH FRACTURE 111
841 CATHETER SITE HAEMORRHAGE 110
842 NEUTROPENIC SEPSIS 110
843 NO THERAPEUTIC RESPONSE 110
844 PAIN OF SKIN 110
845 RESPIRATORY RATE INCREASED 110
846 TOOTH LOSS 110
847 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 109
848 JOINT RANGE OF MOTION DECREASED 109
849 NODULE 109
850 CARDIOACTIVE DRUG LEVEL INCREASED 108
851 DERMATITIS 108
852 MUSCULOSKELETAL DISORDER 108
853 PERIPHERAL COLDNESS 108
854 TOOTH EXTRACTION 108
855 DERMATITIS ATOPIC 107
856 ERECTILE DYSFUNCTION 107
857 INJECTION SITE MASS 107
858 JOINT DISLOCATION 107
859 MYOPATHY 107
860 SKIN INFECTION 107
861 AORTIC ANEURYSM 106
862 BUNDLE BRANCH BLOCK RIGHT 106
863 HIP ARTHROPLASTY 106
864 INFUSION SITE PRURITUS 106
865 LARGE INTESTINE POLYP 106
866 SKIN IRRITATION 106
867 TEMPERATURE INTOLERANCE 106
868 APHONIA 105
869 PLATELET COUNT INCREASED 105
870 RED CELL DISTRIBUTION WIDTH INCREASED 105
871 THERAPY PARTIAL RESPONDER 105
872 AMMONIA INCREASED 104
873 ANAL INCONTINENCE 104
874 ANGINA UNSTABLE 104
875 FACIAL PAIN 104
876 MUSCLE STRAIN 104
877 RED BLOOD CELL SEDIMENTATION RATE INCREASED 104
878 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 103
879 LYMPHOPENIA 103
880 MOOD ALTERED 103
881 SLEEP DISORDER THERAPY 103
882 TARDIVE DYSKINESIA 103
883 ACUTE PULMONARY OEDEMA 102
884 CAROTID ARTERY STENOSIS 102
885 CHOLECYSTECTOMY 102
886 PANCREATIC CARCINOMA 102
887 VITAMIN D DECREASED 102
888 CARDIAC FLUTTER 101
889 DEVICE DIFFICULT TO USE 101
890 HYPOAESTHESIA ORAL 101
891 ANALGESIC THERAPY 100
892 ANGER 100
893 ATRIOVENTRICULAR BLOCK COMPLETE 100
894 BLOOD THYROID STIMULATING HORMONE INCREASED 100
895 COLITIS ISCHAEMIC 100
896 EYE HAEMORRHAGE 100
897 GASTRIC HAEMORRHAGE 100
898 METASTASES TO CENTRAL NERVOUS SYSTEM 100
899 MULTIPLE MYELOMA 100
900 PROTEIN TOTAL DECREASED 100
901 PULMONARY HAEMORRHAGE 100
902 BLOOD CREATINE INCREASED 99
903 DELUSION 99
904 EAR DISCOMFORT 99
905 ORAL HERPES 99
906 PERITONITIS BACTERIAL 99
907 DEVICE MAINTENANCE ISSUE 98
908 PHARYNGEAL OEDEMA 98
909 PLEURITIC PAIN 98
910 AZOTAEMIA 97
911 IMPAIRED WORK ABILITY 97
912 SQUAMOUS CELL CARCINOMA 97
913 TENDONITIS 97
914 BRONCHIECTASIS 96
915 CATHETER SITE INFECTION 96
916 COORDINATION ABNORMAL 96
917 CORONARY ARTERY STENOSIS 96
918 DRUG EFFECT INCOMPLETE 96
919 FRACTURE 96
920 METABOLIC ALKALOSIS 96
921 POLYP 96
922 PRE-EXISTING CONDITION IMPROVED 96
923 PURPURA 96
924 PURULENT DISCHARGE 96
925 REFUSAL OF TREATMENT BY PATIENT 96
926 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 96
927 STENT PLACEMENT 96
928 ABDOMINAL TENDERNESS 95
929 MOUTH HAEMORRHAGE 95
930 OROPHARYNGEAL DISCOMFORT 95
931 PRODUCT DISTRIBUTION ISSUE 95
932 PRODUCT STORAGE ERROR 95
933 SPINAL OPERATION 95
934 BLOOD POTASSIUM ABNORMAL 94
935 CATHETER SITE ERYTHEMA 94
936 EMBOLISM 94
937 FOOT DEFORMITY 94
938 GASTROINTESTINAL INFECTION 94
939 INJECTION SITE EXTRAVASATION 94
940 SPINAL COLUMN STENOSIS 94
941 APPETITE DISORDER 93
942 BLOOD DISORDER 93
943 CHOLECYSTITIS ACUTE 93
944 CYTOMEGALOVIRUS INFECTION 93
945 DEVICE BREAKAGE 93
946 DRUG THERAPY 93
947 GASTRITIS EROSIVE 93
948 HAEMOLYTIC ANAEMIA 93
949 HYPERCAPNIA 93
950 INJECTION SITE RASH 93
951 INTESTINAL ISCHAEMIA 93
952 JOINT EFFUSION 93
953 LEFT ATRIAL DILATATION 93
954 NEEDLE ISSUE 93
955 ORAL DISCOMFORT 93
956 WALKING AID USER 93
957 BLOOD LOSS ANAEMIA 92
958 INCORRECT DRUG ADMINISTRATION DURATION 92
959 CANDIDIASIS 91
960 CHEST X-RAY ABNORMAL 91
961 LARYNGITIS 91
962 LUNG CONSOLIDATION 91
963 STAPHYLOCOCCAL BACTERAEMIA 91
964 CATARACT OPERATION 90
965 PRESCRIBED OVERDOSE 90
966 AORTIC ARTERIOSCLEROSIS 89
967 GINGIVAL PAIN 89
968 HUMERUS FRACTURE 89
969 PEPTIC ULCER 89
970 PERICARDITIS 89
971 BOWEL MOVEMENT IRREGULARITY 88
972 ESCHERICHIA URINARY TRACT INFECTION 88
973 FAECAL INCONTINENCE 88
974 GENERALISED TONIC-CLONIC SEIZURE 88
975 OBSTRUCTIVE SLEEP APNOEA SYNDROME 88
976 PARALYSIS 88
977 TOXIC SKIN ERUPTION 88
978 VARICOSE VEIN 88
979 BLINDNESS UNILATERAL 87
980 CYST 87
981 ENTEROCOCCAL INFECTION 87
982 EPILEPSY 87
983 HYPERURICAEMIA 87
984 HYPOTONIA 87
985 INTESTINAL PERFORATION 87
986 PRODUCT AVAILABILITY ISSUE 87
987 STAPHYLOCOCCAL SEPSIS 87
988 ABDOMINAL HERNIA 86
989 BLOOD GLUCOSE FLUCTUATION 86
990 MALIGNANT MELANOMA 86
991 NEOPLASM 86
992 PHARYNGITIS 86
993 SENSORY DISTURBANCE 86
994 ACUTE CORONARY SYNDROME 85
995 BLOOD PRESSURE SYSTOLIC DECREASED 85
996 HEART RATE ABNORMAL 85
997 MOOD SWINGS 85
998 PRODUCT PHYSICAL ISSUE 85
999 RESPIRATION ABNORMAL 85